相关实验视频
Updated: Jun 23, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
用膜融合媒介将治疗性siRNA加载到外体中,用于特定组织的应用
Miao Xie1, Yuqing Wu2, Yilun Zhang1
1School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, Shanghai, 200240, P. R. China.
研究人员开发了一种混合外体体载体,用于向siRNA输送,以治疗干眼疾病. 这种新的方法增强了核酸药物输送超出肝脏,显示了治疗潜力.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 眼科医生 眼科 眼科
背景情况:
- 除了肝脏之外,组织特异性输送寡核酸治疗药物是一个重大挑战.
- 外体显示出作为核酸药物输送的天然载体的希望,但面临临临床障碍.
- 开发高效和有针对性的输送系统对于推动核酸疗法的发展至关重要.
研究的目的:
- 开发一种混合外体体载体 (HEV) 用于向的siRNA输送.
- 研究HEV在治疗干眼疾病 (DED) 的潜力.
- 为组织特异性核酸输送建立一个多功能平台.
主要方法:
- 使用DNA拉链介导膜融合构建了一个HEV.
- 含有抗NFKBIZ siRNA的合脂质体与角膜表皮细胞 (CEC) 衍生的外体.
- 在DED小鼠模型中评估了HEV向,siRNA传递和治疗疗效.
主要成果:
- 成功创建了能够准角膜上皮细胞的HEV.
- 通过HEVs向角膜提供有效的siRNA.
- 通过NFKBIZ基因沉默在DED小鼠模型中显著降低了促炎细胞因子和治疗结果.
结论:
- 开发的HEV平台可以实现高效的,组织特异的siRNA传递.
- 在干眼疾病治疗中,HEVs具有显著的治疗潜力.
- 这种混合外体战略为各种疾病治疗提供了一个多功能平台.
更多相关视频
08:29Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
相关概念视频
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
SNAREs and Membrane Fusion
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...